Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
0.920
-0.036 (-3.82%)
At close: May 8, 2024, 4:00 PM
0.990
+0.070 (7.61%)
After-hours: May 8, 2024, 7:54 PM EDT
Bionano Genomics Stock Forecast
BNGO's stock price has decreased by -87.34% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 769.57% from the current stock price of 0.92.
Analyst Consensus: Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
The average analyst rating for BNGO stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +552.17% | Mar 7, 2024 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2023 |
BTIG | BTIG | Strong Buy Maintains $2 → $10 | Strong Buy | Maintains | $2 → $10 | +986.96% | Aug 10, 2023 |
BTIG | BTIG | Strong Buy Maintains $30 → $20 | Strong Buy | Maintains | $30 → $20 | +2,073.91% | May 18, 2023 |
BTIG | BTIG | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +3,160.87% | Apr 24, 2023 |
Financial Forecast
Revenue This Year
39.52M
from 36.12M
Increased by 9.42%
Revenue Next Year
51.93M
from 39.52M
Increased by 31.40%
EPS This Year
-1.93
from -6.81
EPS Next Year
-1.30
from -1.93
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 42.3M | 56.9M | 78.0M | 106.7M | 145.7M |
Avg | 39.5M | 51.9M | 75.8M | 103.7M | 141.5M |
Low | 36.8M | 48.0M | 72.8M | 99.6M | 136.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 17.2% | 44.0% | 50.3% | 40.8% | 40.5% |
Avg | 9.4% | 31.4% | 46.0% | 36.8% | 36.5% |
Low | 1.8% | 21.5% | 40.2% | 31.4% | 31.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.28 | -0.58 | -0.36 |
Avg | -1.93 | -1.30 | -0.35 |
Low | -2.30 | -1.78 | -0.33 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.